Document Detail


Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance.
MedLine Citation:
PMID:  16138814     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The ongoing problem of emerging antimicrobial resistance has been likened to a balloon where settling one specific issue results in a 'bulge' of even worse problems. However, much has been learned about how to best use our critical antibacterial agents in ways to avoid or even repair some of the resistance damage that has been done. A compilation of current literature strongly suggests that to slow the development of resistance to antimicrobial agents it is optimal to use drugs with more than one mechanism of action or target, to prescribe those with demonstrated ability to minimise or reverse resistance problems, and to avoid underdosing of potent antibiotics. The most recent information also indicates that it is best to limit empirical use of beta-lactam plus fluoroquinolone combination therapy, since these two classes activate some common resistance responses, and using them together can facilitate multidrug resistance in important pathogens, particularly Pseudomonas aeruginosa and Acinetobacter species. This review discusses the role of each major antimicrobial class on resistance development and presents specific strategies for combating the growing problem of multidrug-resistant bacteria. We now have the knowledge to better manage our antimicrobial agent prescribing practices, but finding the will and resources to apply our understanding remains a formidable challenge.
Authors:
L R Peterson
Related Documents :
17913214 - Profile of bacterial isolates from suspected cases of infective endocarditis (ie): a re...
1737444 - Therapeutic and epidemiologic recommendations to reduce the spread of type-i beta-lacta...
17535364 - Resistance to ocular antibiotics: an overview.
6771864 - Treatment failures secondary to in vivo development of drug resistance by microorganisms.
11293654 - Isolation and insecticidal effects of some bacteria from euproctis chrysorrhoea l. (lep...
1337234 - Pathogenicity and preliminary antigenic characterization of six infectious bursal disea...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases     Volume:  11 Suppl 5     ISSN:  1198-743X     ISO Abbreviation:  Clin. Microbiol. Infect.     Publication Date:  2005 Oct 
Date Detail:
Created Date:  2005-09-05     Completed Date:  2006-01-10     Revised Date:  2006-11-07    
Medline Journal Info:
Nlm Unique ID:  9516420     Medline TA:  Clin Microbiol Infect     Country:  France    
Other Details:
Languages:  eng     Pagination:  4-16     Citation Subset:  IM    
Affiliation:
Evanston Northwestern Healthcare, The Feinberg School of Medicine at Northwestern University, Evanstown, IL 60201, USA. lancer@northwestern.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Bacterial Agents / administration & dosage,  classification,  therapeutic use*
Drug Resistance, Bacterial*
Drug Resistance, Multiple, Bacterial
Humans
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The Messiha and Schiavo cases: third-party ethical and legal [corrected] interventions in futile car...
Next Document:  An evidence-based evaluation of important aspects of empirical antibiotic therapy in febrile neutrop...